Pharmafile Logo
Pharmafocus logo
Advanced Search

Genentech

Showing 15 posts of 91 posts found.

genentechlr_copy

Five deaths linked to Roche’s haemophilia drug Hemlibra

March 28, 2018
Research and Development Genentech, Hemlibra, Roche, haemophilia, pharma

Roche has been rocked by the revelation that there have been five patient deaths linked to the use of its …

News
genentechlr

Genentech seals deal with DiCE Molecules

December 20, 2017
Research and Development, Sales and Marketing DiCE, Genentech, Sanofi, biotech, drugs, pharma, pharmaceutical

Genentech has followed in the footsteps of its parent company by signing a drug discovery agreement with DiCE Molecules. The …

News
arvinas-0004168-2

Genentech cements relationship with Arvinas with $650m deal

November 16, 2017
Research and Development, Sales and Marketing Arvinas, Genentech, Roche, biotech, drugs, pharma, pharmaceutical

Genentech first signed a deal with Arvinas, a biotech focused on drugs within the protein degradation class, back in 2015. …

News
aspen

South Africa’s over-charging case against Aspen dissolves, remains against big names

October 6, 2017
Medical Communications, Sales and Marketing Genentech, Pfizer, Roche, aspen, biotech, drugs, pharma, pharmaceutical

South Africa’s Competition Commission has admitted that there is no case to be heard against Aspen and Equity, in regards …

News
genentechlr

FDA approves treatment to counter CAR-T side-effects

August 31, 2017
Medical Communications, Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical

On the day that FDA announced the first CAR-T therapy would be given market authorisation, it also announced that a …

News
roche__tree

Roche’s drug scores expanded FDA indication in advanced bladder cancer

April 18, 2017
Manufacturing and Production, Sales and Marketing Genentech, Roche, tecentriq

Roche’s Genentech has revealed that its immunotherapy drug Tecentriq (atezolizumab) is now enjoying an expanded indication in the US after …

News
roche_close

First treatment for form of MS approved by FDA

March 30, 2017
Sales and Marketing Biogen, Genentech, MS, Roche

In big news for sufferers of MS and the company that developed the drug, Roche subsidiary Genetech, the FDA has …

News
shutterstock_311949818

Genentech plans second Phase 3 Alzheimer’s trial following endpoint failures

March 20, 2017
Research and Development, Sales and Marketing Alzheimer's, Genentech, Roche

Genentech, Roche’s biotech group, has announced its plans to conduct a second Phase 3 study for crenezumab, its anti-Abeta antibody …

News
mylan

Mylan’s pathway to launch of biosimilar to Herceptin cleared by Roche

March 13, 2017
Manufacturing and Production, Sales and Marketing Genentech, Herceptin, Mylan, Roche, biosimilar

Mylan scored a big victory in its plan to launch its biosimilar to Roche’s blockbuster, Herceptin, after Roche and itself …

News
rick_fair

Genentech oncology head leaves for Bellicum CEO role

February 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bellicum, Genentech, Roche, tecentriq

Bellicum Pharmaceuticals has snatched up Genentech’s Rick Fair as its new CEO and President. Fair moves to Bellicum from Genentech …

Appointment

Juno Therapeutics bring in new executive vice president

January 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Roche, juno therapeutics

Juno Therapeutics has hired Corsee D. Sanders as its executive vice president and head of development operations. She will step …

Appointment
roche__tree

Roche’s ground-breaking MS drug delayed by manufacturing issues

December 22, 2016
Genentech, MS, Roche, multiple sclerosis

Roche has released both good and bad news just before Christmas. The good news is very good news for individuals …

News
bill_anderson

Genentech announces Bill Anderson as new CEO

December 16, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bill Anderson, Genentech, Roche

Genentech, the biotech subsidiary of Roche, has announced that Genentech veteran, Ian Clark, will retire as CEO on 1 January. …

Appointment

Roche’s immunotherapy cancer drug given FDA approval

October 19, 2016
Research and Development Cancer, FDA, Genentech, Roche, immunotherapy, lung cancer

Coming off the back of earlier positive news this month, Roche has revealed that their drug, Tecentriq, has been given …

News
hanmi

Hanmi Pharmaceutical raided over insider trading suspicions

October 17, 2016
Sales and Marketing Boehringer Ingelheim, Genentech, Hanmi Pharmaceutical, south korea

At the end of September, we reported on a busy 24-hour for Hanmi Pharmaceutical, as they secured a deal with …

News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024